Gruppo Oncologico Del Nord-ovest

This study tests whether a special supplement called a postbiotic can reduce side effects and improve the immune response in people with advanced head and neck cancer who are receiving standard immunotherapy (pembrolizumab). About 45 participants will receive either the postbioti…

This study is for people with colorectal cancer that can be removed by surgery. Before surgery, participants will receive a short course of targeted drugs chosen based on their tumor's specific genetic makeup. The goal is to see if this approach can shrink or eliminate the cancer…

This study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy and targeted therapy can help people with a specific type of advanced colorectal cancer live longer without their disease getting worse. The trial enrolls 238 adults whose cancer has spre…

This study tests a new combination of three drugs (trastuzumab-deruxtecan, capecitabine, and bevacizumab) as a first treatment for people with HER-2 positive colorectal cancer that has spread or cannot be removed by surgery. The goal is to see how many patients' tumors shrink or …